Table 2.
Gene and Instrument SNPa |
Cytosine-Phosphate-Guanine Site | |||||
---|---|---|---|---|---|---|
cg03636183 in F2RL3 | cg19859270 in GPR15 | |||||
βb | 95% CI | P Value | βb | 95% CI | P Value | |
BDNF-AS | ||||||
rs4074134 | −0.64 | −0.84, −0.45 | 3.9 × 10−10 | −0.21 | −0.27, −0.15 | 1.7 × 10−10 |
rs4923457 | −0.64 | −0.84, −0.45 | 4.0 × 10−10 | −0.21 | −0.27, −0.15 | 1.7 × 10−10 |
rs4923460 | −0.65 | −0.85, −0.45 | 4.7 × 10−10 | −0.21 | −0.27, −0.15 | 3.0 × 10−10 |
IREB2 | ||||||
rs1964678 | −0.47 | −0.65, −0.29 | 6.5 × 10−7 | −0.20 | −0.26, −0.14 | 9.4 × 10−11 |
HYKK | ||||||
rs952216 | −0.47 | −0.65, −0.29 | 6.2 × 10−7 | −0.20 | −0.26, −0.15 | 1.7 × 10−11 |
rs11636131 | −0.48 | −0.67, −0.29 | 7.9 × 10−7 | −0.21 | −0.27, −0.15 | 1.4 × 10−11 |
rs11632604 | −0.48 | −0.67, −0.29 | 8.1 × 10−7 | −0.21 | −0.27, −0.15 | 1.4 × 10−11 |
rs12910289 | −0.49 | −0.68, −0.30 | 6.6 × 10−7 | −0.22 | −0.28, −0.16 | 1.1 × 10−11 |
rs1504546 | −0.48 | −0.67, −0.29 | 8.8 × 10−7 | −0.21 | −0.27, −0.15 | 1.5 × 10−11 |
rs12916999 | −0.48 | −0.67, −0.29 | 9.1 × 10−7 | −0.21 | −0.27, −0.15 | 1.5 × 10−11 |
PSMA4 | ||||||
rs12915366 | −0.48 | −0.66, −0.29 | 9.6 × 10−7 | −0.21 | −0.27, −0.15 | 1.5 × 10−11 |
rs12916483 | −0.48 | −0.66, −0.29 | 9.7 × 10−7 | −0.21 | −0.27, −0.15 | 1.5 × 10−11 |
rs3813571 | −0.46 | −0.64, −0.27 | 1.8 × 10−6 | −0.21 | −0.27, −0.15 | 2.2 × 10−11 |
CHRNA3 | ||||||
rs1317286 | —c | — | — | −0.18 | −0.25, −0.11 | 5.2 × 10−7 |
GRSd | −0.18 | −0.30, −0.07 | 2.4 × 10−3 | −0.11 | −0.15, −0.07 | 1.5 × 10−7 |
Abbreviations: BDNF-AS, brain-derived neurotrophic factor antisense RNA; CHRNA3, cholinergic receptor, nicotinic α 3; CI, confidence interval; F2RL3, coagulation factor II (thrombin) receptor-like 3; GENOA, Genetic Epidemiology Network of Arteriopathy; GPR15, G protein-coupled receptor 15; GRS, genetic risk score; HYKK, hydroxylysine kinase; IREB2, iron-responsive element binding protein 2; PSMA4, proteasome subunit α 4; SNP, single nucleotide polymorphism.
a The instrument SNPs were identified in previous genome-wide association studies of cigarette smoking in an independent cohort and satisfied the assumptions of Mendelian randomization in GENOA.
b β coefficient for the exposure (current smoking status) in the second stage of 2-stage least-squares regression analysis. In all models, results were adjusted for age, sex, plate, 4 principal components, 5 cell proportions, and random intercepts for family.
c Missing data for the Mendelian randomization results because of the violation of assumption 2.
d GRS = [rs4074134 + (2 − rs1964678) + (2 − rs952216) + (2 − rs12915366) + (2 − rs1317286)]/5. When the coded allele was negatively associated with current smoking status, we coded for the other allele by subtracting the allele dosage from 2.